Raymond E. Jones

3.1k citations

40 papers · 2.6k indexed · h-index 25

Impact in

Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer
- Protein Kinase Regulation and GTPase Signaling
- Connexins and lens biology
Oncology top 5%
- Cancer-related Molecular Pathways

Papers in

Organic Chemistry 10
- Quinazolinone synthesis and applications 9
- Synthesis and Biological Evaluation 6
Molecular Biology 22
- PI3K/AKT/mTOR signaling in cancer 8
- Connexins and lens biology 5
- Molecular Biology Techniques and Applications 4

Co-authors: Deborah Defeo-Jones Hans E. Huber Stanley F. Barnett R. Robinson Kathleen Haskell Zhijian Zhao George D. Hartman Craig W. Lindsley
Journals: Bioorganic & Medicinal Chemistry Letters (10 papers)Journal of Biological Chemistry (5 papers)Molecular and Cellular Biology (3 papers)Nature (2 papers)The Journal of Cell Biology (1 paper)
Partner nations: United States Canada Hungary

In The Last Decade

Raymond E. Jones

39 papers receiving 2.5k citations

Peers

Countries citing papers authored by Raymond E. Jones

Since Specialization

Citations

This map shows the geographic impact of Raymond E. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond E. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond E. Jones more than expected).

Fields of papers citing papers by Raymond E. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond E. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond E. Jones. The network helps show where Raymond E. Jones may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Raymond E. Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raymond E. Jones Line = papers co-authored together Raymond E. Jones links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Allosteric inhibitors of Akt1 and Akt2: A naphthyridinone with efficacy in an A2780 tumor xenograft model Bioorganic & Medicinal Chemistry Letters ·Mark T. Bilodeau, Fatou Niasse Dia, J. M. HOFFMAN, Peter J. Manley, Stanley F. Barnett, Deborah Defeo-Jones, Kathleen Haskell, Raymond E. Jones, Karen Leander, R. Robinson, Anthony M. Smith, Hans E. Huber, George D. Hartman	2008	56
2	Development of Pyridopyrimidines as Potent Akt1/2 Inhibitors Bioorganic & Medicinal Chemistry Letters ·Zhicai Wu, A Gabelmann, Y. Iitsuka, R. Robinson, Sheng Fu, Stanley F. Barnett, Deborah Defeo-Jones, Raymond E. Jones, Astrid M. Kral, Hans E. Huber, George D. Hartman, Mark T. Bilodeau	2008	23
3	Discovery of potent and cell-active allosteric dual Akt 1 and 2 inhibitors Bioorganic & Medicinal Chemistry Letters ·Tony Siu, Jun Liang, Myoung-chul Kim, Yiwei Li, Raymond E. Jones, Deborah Defeo-Jones, Stanley F. Barnett, R. Robinson	2008	12
4	Allosteric inhibitors of Akt1 and Akt2: Discovery of [1,2,4]triazolo[3,4-f][1,6]naphthyridines with potent and balanced activity Bioorganic & Medicinal Chemistry Letters ·Yiwei Li, Jun Liang, Tony Siu, Essa Hu, Michael Rossi, Stanley F. Barnett, Deborah Defeo-Jones, Raymond E. Jones, R. Robinson, Karen Leander, Hans E. Huber, Sachin Mittal, Nicholas D. P. Cosford, Peppi Prasit	2008	49
5	Development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved physical properties and cell activity Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao, R. Robinson, Stanley F. Barnett, Deborah Defeo-Jones, Raymond E. Jones, George D. Hartman, Hans E. Huber, Mark E. Duggan, Craig W. Lindsley	2007	38
6	Rapid assembly of diverse and potent allosteric Akt inhibitors Bioorganic & Medicinal Chemistry Letters ·Zhicai Wu, R. Robinson, Sheng Fu, Stanley F. Barnett, Deborah Defeo-Jones, Raymond E. Jones, Astrid M. Kral, Hans E. Huber, Nancy E. Kohl, George D. Hartman, Mark T. Bilodeau	2007	41
7	Optimization of 2,3,5-trisubstituted pyridine derivatives as potent allosteric Akt1 and Akt2 inhibitors Bioorganic & Medicinal Chemistry Letters ·A Gabelmann, Stanley F. Barnett, Mark T. Bilodeau, Deborah Defeo-Jones, George D. Hartman, Hans E. Huber, Raymond E. Jones, Astrid M. Kral, R. Robinson, Zhicai Wu	2007	22
8	Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao, William Leister, R. Robinson, Stanley F. Barnett, Deborah Defeo-Jones, Raymond E. Jones, George D. Hartman, Joel R. Huff, Hans E. Huber, Mark E. Duggan, Craig W. Lindsley	2005	125
9	Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors Biochemical Journal ·Stanley F. Barnett, Deborah Defeo-Jones, Sheng Fu, Ashok Yadav, Kathleen Haskell, Raymond E. Jones, Jason A. Kahana, Astrid M. Kral, Karen Leander, Nneka Adaobi Ochuba, John Malinowski, Elizabeth McAvoy, Debbie Nahas, R. Robinson, Hans E. Huber	2005	326
10	Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors Bioorganic & Medicinal Chemistry Letters ·Craig W. Lindsley, Zhijian Zhao, William Leister, R. Robinson, Stanley F. Barnett, Deborah Defeo-Jones, Raymond E. Jones, George D. Hartman, Joel R. Huff, Hans E. Huber, Mark E. Duggan	2004	415
11	A peptide–doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo Nature Medicine ·Deborah Defeo-Jones, Victor M. Garsky, Bradley K. Wong, Dong-Mei Feng, Proy Vega B, Kathleen Haskell, DAVID M. KIEFER, Karen Leander, Elizabeth McAvoy, Patricia K. Lumma, Jenny Wai, Hui-Min Lu, Sherri L. Motzel, Kevin J Keenan, D. M. JONES, Jiunn H. Lin, Roger Freidinger, Joel R. Huff, Allen Oliff, Raymond E. Jones	2000	127
12	Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to the retinoblastoma gene product Journal of General Virology ·Kathleen Haskell, Gerald A. Vuocolo, Deborah Defeo-Jones, Raymond E. Jones, M Ivey-Hoyle	1993	15
13	Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts Journal of Virology ·Deborah Defeo-Jones, Gerald A. Vuocolo, Kathleen Haskell, Michelle G. Hanobik, DAVID M. KIEFER, Elizabeth McAvoy, M Ivey-Hoyle, Janet L. Brandsma, Allen Oliff, Raymond E. Jones	1993	53
14	Lovastatin Selectively Inhibits ras Activation of the 12-O-Tetradecanoylphorbol-13-Acetate Response Element in Mammalian Cells Molecular and Cellular Biology ·Deborah Defeo-Jones, Venkata Harish, Raymond E. Jones, Gerald A. Vuocolo, Kathleen Haskell, Ronald Wegrzyn, Allen Oliff	1991	9
15	Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product Nature ·Deborah Defeo-Jones, Pearl S. Huang, Raymond E. Jones, Kathleen Haskell, Gerald A. Vuocolo, Michelle G. Hanobik, Hans E. Huber, A Oliff	1991	297
16	Antibodies Specific for the Human Retinoblastoma Protein Identify a Family of Related Polypeptides Molecular and Cellular Biology ·Qianjin Hu, Carmelita Bautista, Gwynneth M. Edwards, Deborah Defeo-Jones, Raymond E. Jones, Ed Harlow	1991	41
17	Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein. Journal of Biological Chemistry ·Raymond E. Jones, Ronald Wegrzyn, Denis R. Patrick, Hans Anton Salomonsen, Gerald A. Vuocolo, Mark W. Riemen, Deborah Defeo-Jones, V M Garsky, David Heimbrook, Allen Oliff	1990	73
18	Conservation of δ-crystallin gene structure between ducks and chickens Journal of Molecular Evolution ·Joram Piatigorsky, Barbara Norman, Raymond E. Jones	1987	17
19	Transcription and site-specific hypomethylation of the delta-crystallin genes in the embryonic chicken lens. Journal of Biological Chemistry ·Raymond E. Jones, Deborah DeFeo, Joram Piatigorsky	1981	31
20	Initial studies on cultured embryonic chick lens epithelial cells infected with a temperature-sensitive Rous sarcoma virus Vision Research ·Raymond E. Jones, Deborah DeFeo, Joram Piatigorsky	1981	16

About Raymond E. Jones

Raymond E. Jones is a scholar working on Organic Chemistry, Molecular Biology, Genetics, Ophthalmology and Oncology, having authored 40 papers that have together received 2.6k indexed citations. Recurring topics across this work include Quinazolinone synthesis and applications (9 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Virus-based gene therapy research (7 papers), Synthesis and Biological Evaluation (6 papers), Connexins and lens biology (5 papers), Molecular Biology Techniques and Applications (4 papers), Cervical Cancer and HPV Research (4 papers) and Prostate Cancer Treatment and Research (4 papers). The work is most often cited by research in Molecular Biology (1.7k citations), Oncology (628 citations), Organic Chemistry (584 citations), Ophthalmology (113 citations) and Cancer Research (177 citations). Raymond E. Jones has collaborated with scholars based in United States, Canada and Hungary. Frequent co-authors include Deborah Defeo-Jones, Hans E. Huber, Stanley F. Barnett, R. Robinson, Kathleen Haskell, Zhijian Zhao, George D. Hartman, Craig W. Lindsley, Mark E. Duggan and Gerald A. Vuocolo. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, Molecular and Cellular Biology, Nature and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact